BTLA and systemic inflammatory response syndrome: Mechanistically, the upregulation of BTLA on CD4+ T cells induced by SIRS such as IL-6 and TNF-α suppresses signaling by phosphorylating SHP1/2 and, simultaneously, provides a pro-survival signal upon activating the PI3K-Akt signaling pathway.